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RECOMBINANT rat interferon , stimulated the contractility
ofisolated rat ileum at doses of4-12 units/ml. Muscarinic
cholinoceptors were involved, as treatment of the tissue
with atropine prevented the contractile response of the
ileum. Furthermore, interferon 3’ increased the affinity of
carbachol for the cholinoceptors and did not change
its maximum effect. Neurogenic pathways were also
involved since pretreatment of ileum with hexamethon-
ium, hemicholinium or tetrodotoxin impaired the con-
tractile effect of interferon 3’- In contrast to the action of
exogenous carbachol, the effects of interferon 3’ are in-
direct. They appear to involve a G protein regulating
phosphoinositide turnover and cytoskeletal structures
since they could not be induced in ileum strips that were
pretreated with pertussis toxin, phospholipase C inhibi-
tors (2-nitro-carboxyphenyl, NN-diphenyl carbamate and
neomycin), cytochalasine B or colchicine.
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Introduction
Interferon gamma (IFN,) is a glycoprotein with
antiviral activity that is involved in a variety of
immunoregulatory processes. In addition to its ef-
fects on immune cell function, it can modulate
smooth muscle" and intestinal epithelial cell growth.
IFNT is known to induce HLA class II antigen expres-
sion on endothelial cells, smooth muscle cells and
enterocytes, and this could be important for the
induction of an autoimmune or inflammatory re-
sponse. The intestine normally contains abundant
IFNT-producing T-lymphocytes, and IFNT release
may occur locally and increase after antigen chal-
lenge. Through its action on tight junction perme-
ability it could affect intestinal epithelial cell contacts
and/or influence the function of the gut by modify-
ing electrolyte transport.
1
Recently we have shown that recombinant rat IFNT
interacts with isolated rat atria, mimicking the action
of a muscarinic cholinergic agonist. Thus, incubation
of rat atria with IFN, decreased tension and cAMP
synthesis and increased cGMP production.
11 In this
study we investigated if INF,, could also alter the
mechanical behaviour of the intestine.
Our results suggest that IFNT imitates the action of
carbachol, a muscarinic cholinergic agent, inducing
the contraction of isolated rat ileum. In contrast to the
exogenously added agonist carbachol, the effects of
IFN, on ileum also involve a nerve-mediated path-
way and are indirect. They require the integrity of the
cytoskeleton and involve a regulatory G protein,
indicating that IFN, reaction with the cholinergic
receptor is complex and probably involves common
signalling pathways.
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Material and Methods
Drugs and reagents: Recombinant rat interferon ,
(rlFNT) was purchased fromAMGEN Biologicals (CA,
USA). Stock solutions containing 107 units/ml were
prepared and stored in aliquots at-70C until used.
Fresh dilutions were prepared immediately before
use. Blocking experiments with monoclonal anti-rat
IFN,(M anti-IFNT, Amgen Biologicals, CA, USA) were
performed by preincubating rIFNT (1 000 U/ml) with
an equal volume ofM anti-IFNT (10 000 U/ml) during
30 min at 37C. According to the providers (Amgen
Biologicals) the activity of IFN, (units/ml) was de-
fined by an antiviral assay whereas one unit of M
anti-IFNT was the amount of antibody sufficient for
neutralization of one unit of rat IFNT antiviral activity.
The reaction mixture was used thereafter, adjusting
the dilution to achieve the final concentration de-
sired in the organ bath. Carbachol, hexamethonium,
hemicholinium, tetrodotoxin, 2-nitro-carboxyphenyl,
NN-diphenyl carbamate (NCDC), neomycin,
cytochalasine B, colchicine, pertussis toxin and atro-
pine were obtained from Sigma (St Louis, MI).
Isolated ileum preparations: Ileum strips were ob-
tained from male albino rats of the Wistar strain
weighing between 200-250 g. The animals were sac-
rificed by decapitation and after excision of the
abdomen coat, the ileum fragments were carefully
dissected. They were placed in Petri dishes filled
with a modified Krebs-Ringer-bicarbonate (KRB)
solution. 11 The ileum was opened longitudinally and
small portions (-1 cm long) were used. The ileum
preparations were mounted in an organ bath con-
taining 15 ml of KRB solution gassed with 5% CO2 in
oxygen and kept at 37C and pH 7.4. One end of the
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tissue was anchored to a stationary glass-holder and
the other was connected to a force transducer
(Stathan UC3 Gold Cell) coupled to an ink-writing
oscillograph (San Ei 180). A constant resting tension
of 750 mg was applied to the tissue preparations by
means of a micrometric device. Only ileum strips that
presented spontaneous contractions were used and
the isometric developed tension (in mg) was re-
corded. Preparations were allowed to equilibrate for
20 min. The contractile tension recorded at this
moment (before delivering IFN, or the drugs) was
considered the initial control. These tension values
(expressed in mg) were obtained by measuring the
amplitude of all the contractions recorded over a
10 min period and calculating their mean value.
These initial magnitudes were compared with the
experimental values and the variations induced by
IFN, or drugs were expressed as percentage changes
with respect to the initial control. The control values
of tension at the end of equilibrium and before the
addition of IFN, or drugs was: 200 + 18 mg (n 50).
Concentration-response curves were constructed
according to van Rossum. 12 Single doses were deliv-
ered in volumes of 0.01 to 0.025 ml of an appropriate
isotonic solution. The total amount of vehicle added
to the bath never exceeded 0.25 ml. The time interval
between doses was that needed by each dose to
produce a maximum effect. Atropine, hexamethon-
ium, hemicholinium, tetrodotoxin, pertussis toxin,
neomycin, cytochalasine B, colchicine or NCDC were
added to the organ bath 30 min before delivering
IFN, or carbachol. At the concentrations used, these
drugs did not alter the baseline.
Results
IFN, induced a concentration-dependent increase
in the contractile activity of isolated ileum. An ori-
ginal tracing showing the pattern of stimulation is
shown in Fig. 1. The stimulatory effect of IFN,
developed gradually, reaching a plateau at 5-10 min.
For this reason the ileum was exposed for a period
of 8-10 min to each concentration (Figs 1 and 2A).
The stimulatory effect of IFN, lasted for 30-40 min
(data not shown). Preincubation of IFN,with M-anti-
IFN, prevented the reaction (Fig. 2A). To determine
whether cholinergic receptors were involved in the
action of IFN% ileum strips were incubated for 30 min
with 10-
M atropine before exposure to IFN,. As
shown in Figs 1 and 2A, the positive effect of IFN,
was antagonized by atropine in a non surmountable
manner. On the other hand, Fig. 2B shows that
atropine antagonized the action of carbachol shifting
the dose-response curve to the right (Fig. 2B).
Moreover, IFN, potentiated the action of carbachol
by increasing the affinity of the cholinoceptor for its
agonist (carbachol) while the maximum effect (gmax)
remained unchanged (Table 1). To determine if the
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cholinergic IFN, effect was nerve mediated, hexa-
methonium (10-6 M), hemicholinium (2 x 10-5 M)
and tetrodotoxin (5 x 10-7 M) were used as inhibitors.
Figure 3A shows a significant reduction of the
stimulatory effect of IFN, when the ileum was
preincubated either with the inhibitor of nicotinic
cholinoceptors (hexamethonium) or with the acetyl
choline (AcCh) synthesis inhibitor (hemicholinium).
Likewise, tetrodotoxin, an inhibitor of propagated
action potentials, reduced the response of the ileum
segment to IFN,. In contrast, these agents did not
modify the response to exogenous carbachol (Fig.
3B). To ascertain whether G regulatory proteins par-
ticipated in the muscarinic cholinergic action of IFN,,
the ileum strips were treated with pertussis toxin. 13
The results shown in Fig. 4A demonstrate that the
stimulatory effect of IFN,was abrogated by pertussis
toxin. In contrast the mechanical response of
pertussis toxin-treated tissue to carbachol remained
unchanged (Fig. 4B). At least one pathway of
cholinoceptor-triggered phosphoinositide is regu-
lated by pertussis toxin-sensitive G proteins that
control activation of phospholipase C. To determine
if phospholipase C was involved in the cholinergic
action of IFN, we performed experiments in which
the phospholipase C activation was inhibited by
NCDCTM or neomycin. 15 The results of Fig. 4A demon-
strate that incubation of ileum with NCDC at a
concentration of 10-M, which is known to
inhibit phospholipase C activity, TM prevented the
effect of IFN,. On the other hand, NCDC did not
alter the inotropic effect of carbachol (Fig. 4B).
The same results were obtained preincubating
ileum with 10-
M neomycin (data not shown).
In order to study if cytoskeletal structures
were involved in the cholinomimetic action of
IFN,, ileum strips were incubated with the
microtubule disrupting agent colchicine, or with
cytochalasine B to prevent microfilament polymeriza-
tion. As shown in Fig. 5A, both colchicine (10-
M)
and cytochalasine B (3 x 10-
M) impaired
the stimulatory action of IFN,. In contrast, neither
agent modified the response to carbachol (Fig. 5B) or
altered the baseline.
Discussion
Although most studies on IFN, activity have fo-
cused on the regulation of the immune response, its
biological effects are pleiotropic. Many classes of
cells bear specific IFN, receptors and respond to IFN,
binding in different ways.1-8 We have recently
shown that IFN, triggered metabolic pathways in
isolated atria that are considered typical of
cholinergic receptor stimulation. 11
In this study we demonstrate that IFN, can increase
the contractile activity of isolated rat ileum (Figs 1
and 2A). This effect was specific for IFN, becauseIFN and ileum contractility
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FIG. 1. Original tracings showing the positive inotropic effect recorded from spontaneously contracting
rat ileum in the absence (upper panel) or in the presence (lower panel) of 10 M atropine (30 min
preincubation) after addition of 2-12 units/ml IFNT;, C: basal values before addition of IFN,.
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FIG. 2. Effects of IFN3, and carbachol on isolated ileum. Dose--response curves of: (A) IFN7 (units/ml) (e--e) or (B) carbachol (-log M) (&--,&) were
constructed on spontaneously contracting rat ileum or ileum that was preincubated with 10 M atropine (A- -A) for 30 min before addition of the reagents.
The action of IFN, neutralized with M anti-IFN7 (O O) was also assayed. Basal values of tension: 200 +/- 18. The results (mean +/- SEM) of 12-15
experiments are shown.
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Table 1. Potentiation of the contractile effect of carbachol by IFNT
Additions Ema (mg) Kd (10--
M) n
Carbachol 680 + 40 15.0 + 1.2 8
Carbachol + IFNT 782 + 62 2.0 + 0.2* 5
Ileum strips were exposed to different concentrations of carbachol
in the absence or in the presence of 2.0 units/ml IFNT. Em,,x: maxi-
mum effect of carbachol; Kd: effective concentration of carbachol
causing 50% of the maximum response. Basal values: 198 + 15 mg
tension; IFNT alone: 205 +/- 15 mg. Values are mean +/- SEM. n rep-
resents the number of experiments. Statistical differences,
carbachol vs. carbachol + IFNT, p < 0.001, Student’s t-test
pretreatment with M anti-IFNT prevented the "action
of IFNT. The contractile response to IFNT involved
muscarinic cholinoceptors, since incubation of the
ileum strips with atropine inhibited the reaction
in a non-competitive manner. Furthermore,
preincubation of the gut with subthreshold doses of
IFNT potentiated the action of carbachol increasing
the affinity of the cholinoceptors without alteration
of the maximum effect (Table 1). It is noteworthy that
the doses of IFNT required to stimulate ileum tension,
and the times of exposure of the tissue to IFNT, are
well below those reported for its action on epithelial
cell lines.9,1 Because IFNT enhances the fragility of
the intestinal epithelial cell barrier, increased peristal-
sis could facilitate damage of the intestinal function
due to the loss of resistance to mechanical stress.
The contractile effects of IFNT appear to be mediated
by muscarinic cholinergic mechanisms. However, the
effect of IFNT was impaired by preincubation of the
tissue with a nicotinic antagonist (hexamethonium).
In contrast to the action of exogenous carbachol at
the concentrations used, the contractile effect of IFNy
was shown to involve both myogenic and
neurogenic pathways. Nicotinic receptors may be
activated directly by IFNT or indirectly by IFNy acting
on preganglionic nerves or cholinergic interneurones
to induce a release of endogenous AcCh, as
hemicholinium opposes its action. However, it could
be that IFNy activates cholinergic interneurones
which release AcCh to act on nicotinic postsynaptic
cholinoceptors; these in turn, could stimulate the
release of AcCh to act on smooth muscle receptors.
IFNy induced firing of propagated action potentials,
as tetrodotoxin impaired its activity. Nevertheless, as
the inhibitory action of tetrodotoxin was only partial,
a direct effect of IFNT on the smooth muscle could
also be suggested. Therefore, the interactions of IFNT
with the cholinoceptor pathways of signal trans-
duction appear to be complex. G proteins could be
a link between IFNT and the metabolic pathways
triggered by muscarinic cholinergic stimulation.
Muscarinic cholinergic receptors (mAcChR) belong
to the family of receptors that are coupled to GTP-
binding regulatory proteins (G proteins). 19 A single
mAcChR can activate more than one type of G
protein to regulate several signal transduction path-
ways. 19 Thus, events that follow muscarinic agonist
binding to mAcChR can be the result of pertussis
toxin sensitive or insensitive G protein coupled path-
ways.2,21 Our results (Fig. 4A) demonstrate that a G
regulatory protein is involved in the interaction be-
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FIG. 3. Participation of the nicotinic cholinergic pathway in the action of IFNT on rat ileum. Dose-response curves of: (A) IFNT (o -o) or (B) carbachol
(,--,I,) were done on ileum incubated in KRB or preincubated during 30 min with hexamethonium (10 M) (.--,), hemicholinium (2 x 10 M) (n--I"1)
and tetrodotoxin (5 x 10 M) (A- -A}. The results are the mean +/- SEM of six experiments.
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FIG. 4. Participation of G proteins and phosphoinositide hydrolysis in the action of IFNT on rat ileum. Dose-response curves of: (A) IFNI, (o- -o) or (B)
carbachol (a &) were done on ileum incubated in KFIB or preincubated during 80 rain with 0.5 pg/ml pertussis toxin (n n) or I0 M NCDC (m m).
The results are the mean SEM of eight experiments.
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FIG. 5. Participation of the cytoskeleton in the contractile effect of IFN7 on rat ileum. Dose-response curves of: (A) IFN7 (e-- e) or (B) carbachol
(&--) were done on ileum incubated in KRB or preincubated during 30 min with 10 M colchicine (O-- O) or 3 x 10 M cytochalasine B (I-- I).
The results are the mean SEM of seven experiments.
tween IFNy and the cholinergic system in the intes-
tine, as pertussis toxin treatment of the tissue pre-
vented the reaction. This contrasts with pertussis
toxin insensitivity of the carbachol-induced stimu-
latory effect in the same experimental system
(Fig. 4B), suggesting that G protein insensitive path-
ways predominate in the contractile effect of
carbachol. Cholinoceptor activation is associated
with phosphoinositide (PI) turnover through
phospholipase C activation13 and smooth muscle
contraction can be induced by inositol triphosphate
(IP3) resulting from PI hydrolysis."" Therefore, we
tested if inhibition of phospholipase C could inter-
fere with the cholinomimetic effect of IFNT on the
intestine. Our results demonstrate that PI turnover is
required for the development of the IFNT contractile
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effect, as NCDC or neomycin treatment of the ileum
strips abolished the reaction (Fig. 4A). Again, the
stimulatory action of carbachol was insensitive to
phospholipase C inhibition (Fig. 4B), indicating that
different metabolic pathways resulting in similar
mechanical effects may be followed by IFN, and
carbachol. Many reactions mediated by G proteins
share common features. 23 Tubulin, a main compo-
nent of the cytoskeleton, has a GTP binding site and
GTPase activity, that are necessary for the polymeri-
zation of the microtubules. 23 To determine if the
cytoskeleton was involved in the reaction triggered
by IFN, on the ileum, we studied the effect of
drugs that interfere with cytoskeletal function
(cytochalasine B to prevent microfilament polymeri-
zation and colchicine for microtubule disruption)
(Fig. 5A and B). While carbachol stimulated
contractility under these conditions, IFN, was inef-
fective. Thus, the cytoskeleton is probably acting as
a link between IFN, and mAcChR. A fundamental
role for the cytoskeleton in the maintenance of the
barrier function of epithelial cells has been pro-
posed. 24,25 Direct effects of IFN, on F-actin distribu-
tion have been demonstrated on vascular endothelial
cells18 and in intestinal epithelial cells subtle changes
in cytoskeletal rearrangement were observed. How-
ever, the amount of IFN, necessary to obtain these
effects was 100 times higher than the dose used to
enhance contractility in this study.
In summary, we have shown that IFN, can trigger
the mechanical response of isolated ileum. This is the
consequence of a complex and indirect interaction
between IFN, and the cholinergic pathway that in-
volves neurogenic and myogenic pathways, the
cytoskeleton, pertussis sensitive G regulatory pro-
teins and PI turnover.
The participation of the gut mucosal immune sys-
tem in the regulation of intestinal function has been
demonstrated.26 In the normal gut there is a balance
in the cytokine network. Under inflammatory condi-
tions or chronic antigenic stimulation at the local
level, this balance is disrupted.
27 Lymphokines pro-
duced by T-lymphocytes could synergize or antago-
nize the effects of neurotransmitters or other
cytokines11,28 and thus influence the inflammatory
response of the intestine. Thus, the contractile effects
of IFN, described in this study could play a role in
chronic inflammatory bowel diseases or in HIV diar-
rhoea, when the balance of the local immune system
is disturbed. 29
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